Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02591615
Title Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCSD Moores Cancer Center La Jolla California 92093 United States Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
NorthShore University HealthSystem Evanston Illinois 60201 United States Details
Medical Oncology & Hematology Associates Des Moines Iowa 50309 United States Details
EMMC Cancer Care Brewer Maine 04412 United States Details
Metro MN Community Oncology Research Consortium Minneapolis Minnesota 55416 United States Details
NH Oncology (Concord) Concord New Hampshire 03301 United States Details
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 United States Details
SUNY Upstate Medical University Syracuse New York 13210 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
University of Oklahoma Health Sciences Center Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
*Shaded cells indicate that there was no data available from for the field